Literature DB >> 4123760

Comparison of therapeutic and immunosuppressive effects of azathioprine, prednisolone and combined therapy in NZP-NZW mice.

B H Hahn, M K Bagby, T R Hamilton, C K Osterland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4123760     DOI： 10.1002/art.1780160205

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  10 in total

1.  Increased survival times of New Zealand hybrid mice immunosuppressed by graft-versus-host reactions.

Authors:  D H Lehman; C B Wilson; F J Dixon
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

2.  Therapeutic effect of beta-[1-phenyl-5-bis(beta-chloroethyl)-amino-benzimidazolyl-(2)-DL-alanin (ZIMET 3164) on immune complex nephritis of NZB hybrid mice.

Authors:  J Güttner
Journal:  Agents Actions       Date:  1979-12

3.  Marrow transplantation from tolerant donors to treat and prevent autoimmune diseases in BXSB mice.

Authors:  K Himeno; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

4.  Therapeutic effect of 15-deoxyspergualin on the progression of lupus nephritis in MRL mice. I. Immunopathological analyses.

Authors:  S Ito; M Ueno; M Arakawa; T Saito; T Aoyagi; M Fujiwara
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

5.  Prognostic significance of DNA-binding capacity patterns in patients with lupus nephritis.

Authors:  M K Adler; A Baumgarten; B Hecht; N J Siegel
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

6.  DNA binding activity of serum from patients with systemic lupus erythematosus.

Authors:  J F Halsey; W A Woolery; S Oleinick; M B Kahaleh; E C Leroy
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

7.  Successful treatment of autoimmune disease in (NZB/NZW)F1 female mice by using fractionated total lymphoid irradiation.

Authors:  S Slavin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

Review 8.  Clinical significance of antibodies to double stranded DNA (dsDNA) for systemic lupus erythematosus (SLE).

Authors:  T Swaak; R Smeenk
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

9.  Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies.

Authors:  N E Adelman; D L Watling; H O McDevitt
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

10.  Reversal of nzb/nzw disease with total lymphoid irradiation.

Authors:  B L Kotzin; S Strober
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.